Breaking News Instant updates and real-time market news.

PCRX

Pacira

$42.65

0.45 (1.07%)

19:24
11/21/17
11/21
19:24
11/21/17
19:24

October Symphony data 'very solid' for Pacira, says BMO Capital

BMO Capital analyst Gary Nachman says Symphony data released tonight for October show sales of Pacira Pharmaceuticals' Exparel were $25.3M, up 19.6% year-over-year and up 17.4% from September. Sales per selling day were up 11.8% from the prior month. Nachman calls the numbers "very solid" and notes he'll look to see if the positive inflection continues. The analyst has a Market Perform rating on Pacira with a $39 price target.

  • 28

    Nov

  • 14

    Dec

  • 06

    Apr

PCRX Pacira
$42.65

0.45 (1.07%)

11/08/17
PIPR
11/08/17
NO CHANGE
Target $49
PIPR
Overweight
Pacira's Exparel well positioned despite guidance cut, says Piper Jaffray
Piper Jaffray analyst David Amsellem lowered his price target for Pacira Pharmaceuticals to $49 from $55 while reiterating an Overweight rating on the shares following this morning's Q3 results. The guidance reduction is not a big one, and Exparel remains well positioned for "significant and sustainable growth" amid the opioid crisis, Amsellem tells investors in a post-earnings research note. He believes management's commentary "should assuage some of the broader investor concerns regarding commercial execution."
11/09/17
JEFF
11/09/17
NO CHANGE
Target $52
JEFF
Buy
Pacira price target lowered to $52 from $57 at Jefferies
Jefferies analyst David Steinberg lowered his price target for Pacira Pharmaceuticals to $52 following the company's Q3 results and reduced revenue outlook. The analyst trimmed his fiscal 2017-2020 revenue estimates by 5% and fiscal 2019-2020 earnings estimates by 7%-10%. He keeps a Buy rating on Pacira.
11/09/17
HCWC
11/09/17
INITIATION
Target $52
HCWC
Buy
Pacira assumed with a Buy at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat assumed coverage of Pacira Pharmaceuticals with a Buy rating and $52 price target. The analyst believes Exparel "should be a long, slow, and steady grower like most historically successful hospital products."
11/16/17
JANY
11/16/17
NO CHANGE
Target $27
JANY
Sell
Exparel AdComm introduces new uncertainty for Pacira, says Janney Capital
Janney Capital analyst Ken Trbovich noted Pacira's announcement that the FDA has decided to bring its sNDA for Exparel as a nerve block to an advisory committee meeting, which he views as introducing a new measure of uncertainty into the review process. Pacira has made public "very little" safety data from its nerve block studies, said Trbovich, who expects the AdComm process to result in the release of more detailed safety data than previously available. He maintains a Sell rating and $27 fair value estimate on Pacira shares.

TODAY'S FREE FLY STORIES

DHI

D.R. Horton

$43.36

0.34 (0.79%)

13:00
04/23/18
04/23
13:00
04/23/18
13:00
Options
DR Horton draws far upside call writing ahead of earnings »

DR Horton draws far…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

FB

Facebook

$167.80

1.51 (0.91%)

12:58
04/23/18
04/23
12:58
04/23/18
12:58
Hot Stocks
DoubleLine's Gundlach says go short Facebook »

Jeffrey Gundlach, CEO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 25

    Apr

XOP

SPDR Oil Exploration and Production Fund

$38.82

-0.06 (-0.15%)

12:58
04/23/18
04/23
12:58
04/23/18
12:58
Hot Stocks
DoubleLine's Gundlach says go long SPDR Oil Exploration and Production Fund »

Jeffrey Gundlach, CEO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APDN

Applied DNA Sciences

12:56
04/23/18
04/23
12:56
04/23/18
12:56
Initiation
Applied DNA Sciences initiated  »

Applied DNA Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

FB

Facebook

$167.77

1.48 (0.89%)

12:55
04/23/18
04/23
12:55
04/23/18
12:55
Hot Stocks
DoubleLine's Gundlach calls apology by Facebook's Zuckerberg 'disingenuous' »

Jeffrey Gundlach, CEO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 25

    Apr

WPG

Washington Prime

12:50
04/23/18
04/23
12:50
04/23/18
12:50
Options
Washington Prime with notable put buying ahead of earnings »

Washington Prime with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

AAPL

Apple

$165.70

-0.01 (-0.01%)

12:48
04/23/18
04/23
12:48
04/23/18
12:48
Hot Stocks
CIRP: iPhone X demand slows as iPhone 8, 8 Plus mix climbs in March quarter »

Consumer Intelligence…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

OAS

Oasis Petroleum

$10.16

0.01 (0.10%)

12:45
04/23/18
04/23
12:45
04/23/18
12:45
Options
Oasis Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

ASND

Ascendis Pharma

$63.01

-0.82 (-1.28%)

12:45
04/23/18
04/23
12:45
04/23/18
12:45
Conference/Events
Ascendis Pharma has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 08

    May

  • 10

    May

CNSL

Consolidated Communications

$10.94

-0.04 (-0.36%)

12:41
04/23/18
04/23
12:41
04/23/18
12:41
Hot Stocks
Consolidated Communications launches DDoS mitigation solution »

Consolidated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$68.72

0.31 (0.45%)

, LLY

Eli Lilly

$79.47

0.38 (0.48%)

12:36
04/23/18
04/23
12:36
04/23/18
12:36
Recommendations
Incyte, Eli Lilly analyst commentary  »

Incyte AdCom meeting…

INCY

Incyte

$68.72

0.31 (0.45%)

LLY

Eli Lilly

$79.47

0.38 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 01

    May

  • 07

    May

  • 21

    May

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

GRUB

GrubHub

$103.01

1.32 (1.30%)

12:35
04/23/18
04/23
12:35
04/23/18
12:35
Hot Stocks
Half Sky's Ran says GrubHub has 'significant room for growth' »

Says young people are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 29

    May

  • 12

    Jun

GRUB

GrubHub

$103.59

1.9 (1.87%)

12:30
04/23/18
04/23
12:30
04/23/18
12:30
Hot Stocks
Half Sky's Ran says GrubHub is "attractive investment idea" »

Li Ran, CIO, Half Sky…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 29

    May

  • 12

    Jun

LITE

Lumentum

$57.25

-1.65 (-2.80%)

12:27
04/23/18
04/23
12:27
04/23/18
12:27
Hot Stocks
Lumentum falls to session lows, down 5% »

Shares of Lumentum have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 29

    May

DHI

D.R. Horton

$43.22

0.2 (0.46%)

12:26
04/23/18
04/23
12:26
04/23/18
12:26
Hot Stocks
Long Pond's Khoury sees D.R. Horton at $71.50 per share »

Says incredibly strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

12:25
04/23/18
04/23
12:25
04/23/18
12:25
General news
NABE Business Conditions Survey showed strong sales expectations »

NABE Business Conditions…

12:25
04/23/18
04/23
12:25
04/23/18
12:25
Conference/Events
Leerink healthcare analysts to hold an analyst/industry conference call »

Analysts discuss dental…

PRTA

Prothena

$11.54

-25.35 (-68.72%)

, RHHBY

Roche

12:23
04/23/18
04/23
12:23
04/23/18
12:23
Recommendations
Prothena, Roche analyst commentary  »

Prothena price target…

PRTA

Prothena

$11.54

-25.35 (-68.72%)

RHHBY

Roche

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 27

    Apr

  • 27

    Apr

  • 21

    May

  • 30

    May

VZ

Verizon

$48.36

0.44 (0.92%)

, T

AT&T

$34.76

0.09 (0.26%)

12:22
04/23/18
04/23
12:22
04/23/18
12:22
Earnings
On The Fly: What to watch in telecom sector earnings reports »

Verizon (VZ) is scheduled…

VZ

Verizon

$48.36

0.44 (0.92%)

T

AT&T

$34.76

0.09 (0.26%)

S

Sprint

$5.91

-0.085 (-1.42%)

TMUS

T-Mobile

$62.59

-0.51 (-0.81%)

TWX

Time Warner

$96.13

-0.1 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 09

    May

AMZN

Amazon.com

$1,535.44

8.05 (0.53%)

, MGM

MGM Resorts

$36.31

0.88 (2.48%)

12:21
04/23/18
04/23
12:21
04/23/18
12:21
Periodicals
'Fortnite' stream in Las Vegas peaked at 667,000 viewers on Twitch, ESPN says »

A high-profile…

AMZN

Amazon.com

$1,535.44

8.05 (0.53%)

MGM

MGM Resorts

$36.31

0.88 (2.48%)

TCEHY

Tencent

DIS

Disney

$100.22

-0.02 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 08

    May

NCR

NCR Corp.

$31.52

-0.03 (-0.10%)

12:20
04/23/18
04/23
12:20
04/23/18
12:20
Options
New positions opened in NCR calls ahead of earnings »

New positions opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHI

D.R. Horton

$43.11

0.09 (0.21%)

12:19
04/23/18
04/23
12:19
04/23/18
12:19
Hot Stocks
Long Pond's Khoury says D.R. Horton is transforming into pure play manufacturer »

Says transformation from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

MMM

3M

$217.06

-0.66 (-0.30%)

12:18
04/23/18
04/23
12:18
04/23/18
12:18
Technical Analysis
Technical Take: 3M in downtrend ahead of earnings news »

The stock has been in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 18

    May

  • 30

    May

$NSD

NASDAQ Market Internals

12:17
04/23/18
04/23
12:17
04/23/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
04/23/18
04/23
12:16
04/23/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.